Table 1 Baseline characteristics
Characteristic | Number (%)1 |
|---|---|
Age (Years) | Â |
  Median | 74.5 |
  Range | 70-86 |
Sex | Â |
  Male | 23 (68%) |
  Female | 11 (32%) |
Histology | Â |
  Adenocarcinoma | 16 (47%) |
  Squamous | 10 (29%) |
  Poorly differentiated | 6 (18%) |
  Large cell/other | 2 (6%) |
Stage 2 | Â |
  IIIB | 8 (24%) |
  IV | 26 (76%) |
ECOG Performance Status (n=32) | Â |
  0 | 10 (29%) |
  1 | 18 (53%) |
  2 | 4 (11%) |
Charlson Comorbidity Score (n=33) | Â |
  Median | 1 |
  Range | 0-7 |
VES-13 Score (n=29) | Â |
  Median | 1 |
  Range | 0-8 |
  VES ≥ 3 (Frail) | 11 (38%) |
Tumor PDGF score (n=14) 3 | Â |
  Median | 75 |
  Range | 0-300 |